NovaBay Pharmaceuticals, Inc.
NBY
$0.58
-$0.02-3.33%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.33% | -58.80% | -41.76% | -9.85% | -21.34% |
| Total Receivables | 28.70% | -25.48% | -3.29% | -17.14% | -65.08% |
| Inventory | -28.86% | 4.95% | -77.39% | -17.74% | -4.80% |
| Prepaid Expenses | 14.91% | -40.59% | 15.81% | 42.68% | -23.36% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 23.40% | -2.08% | 18.52% | 6.58% | -61.62% |
| Total Current Assets | 1.15% | -37.26% | -49.80% | -12.90% | -26.77% |
|
|
|||||
| Total Current Assets | 1.15% | -37.26% | -49.80% | -12.90% | -26.77% |
| Net Property, Plant & Equipment | -7.78% | -7.21% | -6.80% | -14.79% | -6.94% |
| Long-term Investments | -- | -- | -- | -- | 0.00% |
| Goodwill | -- | -- | -- | -- | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -1.72% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.99% | -0.21% | -4.02% | -0.80% | 1.01% |
| Total Assets | -1.22% | -26.73% | -40.70% | -29.71% | -19.72% |
|
|
|||||
| Total Accounts Payable | -67.94% | 10.56% | -1.15% | 19.32% | -36.06% |
| Total Accrued Expenses | -24.43% | 0.58% | -8.60% | -31.08% | -11.83% |
| Short-term Debt | -92.67% | -30.88% | -11.43% | -10.47% | 7.17% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.09% | 1.87% | -24.24% | 2.06% | 1.89% |
| Total Finance Division Other Current Liabilities | -2.85% | -14.49% | -4.44% | -9.21% | -47.53% |
| Total Other Current Liabilities | -2.85% | -14.49% | -4.44% | -9.21% | -47.53% |
| Total Current Liabilities | -45.04% | -8.00% | -8.27% | -6.41% | -24.65% |
|
|
|||||
| Total Current Liabilities | -45.04% | -8.00% | -8.27% | -6.41% | -24.65% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -92.67% | -30.88% | -11.43% | -10.47% | 7.17% |
| Capital Leases | -11.91% | -10.47% | -6.05% | -10.93% | -9.79% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -30.54% | -- | -- |
| Total Liabilities | -38.24% | -12.60% | -9.14% | -1.63% | -21.89% |
|
|
|||||
| Common Stock & APIC | 2.18% | 1.29% | 0.51% | 3.21% | 0.22% |
| Retained Earnings | -1.23% | -0.89% | -2.06% | -5.53% | -1.07% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 271.11% | 52.98% | -197.14% | -73.04% | -21.42% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | -99.60% | -23.85% | -1.37% | -6.92% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | -99.60% | -23.85% | -1.37% | -6.92% |
|
|
|||||
| Total Common Equity | 271.11% | 52.98% | -197.14% | -73.04% | -21.42% |
| Total Preferred Equity | 0.00% | -99.60% | -23.85% | -1.37% | -6.92% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 273.74% | -485.63% | -95.17% | -52.91% | -17.82% |
|
|
|||||
